Literature DB >> 15412213

The standardization of the Wechsler intelligence scale for children.

H SEASHORE, A WESMAN, J DOPPELT.   

Abstract

Entities:  

Keywords:  WECHSLER-BELLEVUE SCALE

Mesh：

Year:  1950        PMID： 15412213     DOI： 10.1037/h0056307

Source DB:  PubMed          Journal:  J Consult Psychol        ISSN： 0022-006X


× No keyword cloud information.
  4 in total

1.  Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy.

Authors:  G G Marsh; T L Munsat
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

2.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

3.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

4.  Cognitive-behavioral family therapy as psychoeducation for adolescents with high-functioning autism spectrum disorders: Aware and Care for my Autistic Traits (ACAT) program study protocol for a pragmatic multisite randomized controlled trial.

Authors:  Fumiyo Oshima; Mandy William; Noriko Takahashi; Aki Tsuchiyagaito; Hitoshi Kuwabara; Akihiro Shiina; Mikuko Seto; Minako Hongo; Yui Iwama; Yoshiyuki Hirano; Chihiro Sutoh; Kayoko Taguchi; Tokiko Yoshida; Yohei Kawasaki; Yoshihito Ozawa; Jiro Masuya; Noriyuki Sato; Shizuka Nakamura; Masaru Kuno; Jumpei Takahashi; Toshiyuki Ohtani; Daisuke Matsuzawa; Naoko Inada; Miho Kuroda; Mika Ando; Arinobu Hori; Akiko Nakagawa; Eiji Shimizu
Journal:  Trials       Date:  2020-09-29       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.